|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Does the List of Approved Drugs Reveal About FDA's Priority Review Voucher Program?
2
Novo Nordisk’s Stock Reacts to Unsuccessful Phase III Trial Results
3
What Successes and Setbacks Occurred in Neurosciences in 2025?
4
Winning the Next Era of Direct-to-Patient Drug Distribution: Why End-to-End Integration Matters More Than Assembly
5
